content

The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate

CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland announced that they have entered into a new, significant partnering agreement...

FDA Approves Merck’s RECARBRIO for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has approved a supplemental New Drug Application (sNDA) for...

UCB Acquires Engage Therapeutics for $125M

UCB announced the acquisition of Engage Therapeutics, Inc., a clinical-stage pharmaceutical company developing StaccatoยฎAlprazolam for the rapid termination of an active epileptic seizure, for...

AI to deliver next evolution of drug manufacturing and supply chain efficiency

In the absence of โ€˜in personโ€™ meetings, access to deep dive pharma insights are not on hold, and later this month experts will discuss...

Lonza to Host New Webinar โ€“ โ€œThe Compendia are ready. Are you? A More Sustainable Future for Endotoxin Testingโ€

On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC)...

Thermo Fisher Scientific to Showcase New Mass Spectrometry Instruments and Software Solutions During Virtual Events

Thermo Fisher Scientific Inc., the world leader in serving science, will provide online programming and virtual exhibits to introduce scientists to a number of...

Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer

Albumedix Ltd., the world leader in recombinant human albumin (rAlb), announced the strengthening of its Executive Leadership with the appointment of Gregor Kawaletz as...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read